Glycated Haemoglobin as an Index of Glycaemic Control: Ethnic Variation among Patients with Type 2 Diabetes Mellitus in a Malaysian Tertiary Hospital

Author:

Arifin Adilah,C. Thambiah Subashini,Abdullah Hafizah,Samsuddin Intan Nureslyna,Zahari Sham Siti Yazmin

Abstract

Introduction: Previous studies have revealed ethnic differences in glycated haemoglobin (HbA1c) value at the same glucose concentration. This study aimed to determine ethnic variation in HbA1c as an index of glycaemic control among type 2 diabetes mellitus (T2DM) patients. Methods: This cross-sectional, retrospective study recruited 293 T2DM patients by simple random sampling at the medical outpatient clinic of a tertiary hospital. Results: Ethnicity was equally distributed with 33.4% Malays and Indians, respectively, and 33.1% Chinese. Significant difference in ethnicity was noted between HbA1c groups ≤6.5% and >6.5%. Indians had the highest median HbA1c (8.3%), followed by Malays (7.7%) and Chinese (7.2%) [p=0.004]. Malays had lower HbA1c compared with Chinese at lower fasting plasma glucose (FPG) whereas Chinese had lower HbA1c compared with Malays at higher FPG, crossing over at FPG 2.8 mmol/L. Indians had higher HbA1c compared with Chinese and Malays except at FPG cross-over of 16 mmol/L where Malays were higher than Indians. FPG and ethnicity were independent predictors of HbA1c. An increase of 1 mmol/L in FPG resulted in an increase of 0.44% in HbA1c. Indians and Malays had 0.60% and 0.47% higher HbA1c, respectively, than Chinese. Conclusion: This pilot study in Malaysia examined ethnic variation in the relationship between FPG and HbA1c among T2DM patients. Since HbA1c is higher in Indians and Malays compared with Chinese at any given FPG, the hypoglycaemia risk may be increased in Indians and Malays when treatment strategies are focussed on using similar target HbA1c values to treat them.

Publisher

Universiti Putra Malaysia

Subject

General Medicine

Reference26 articles.

1. 1. Institute for Public Health, Ministry of Health Malaysia. National Health and Morbidity Survey 2019. Available from: https://iku.moh.gov.my/images/IKU/Document/REPORT/NHMS2019/Report_NHMS2019-NCD_v2.pdf

2. 2. International Society of Nephrology. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 2013. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf

3. 3. Chan SP, Wan Bebakar WM, Hussein Z, et al. Clinical Practice Guidelines Management of Type 2 Diabetes Mellitus 6th Edition. Putrajaya: Ministry of Health Malaysia; 2020. Available from: https://mems.my/wp-content/uploads/2021/01/CPG_T2DM_6thEdition_2020.pdf

4. 4. Hare MJL, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. Journal of Internal Medicine. 2012; 271: 227-236. doi: 10.1111/j.1365-2796.2012.02513.x.

5. 5. Herman WH. Do Race and Ethnicity Impact Haemoglobin A1c Independent of Glycaemia? Journal of Diabetes Science and Technology. 2009; 3(4): 656-660. doi: 10.1177/193229680900300406.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3